News

Genius Group Takes Legal Action Against LZGI Executives

Genius Group Takes Legal Action Against LZGI Executives

Genius Group Takes Legal Action Against LZGI Executives

Genius Group Limited (NYSE: GNS), an innovative educational company utilizing AI technology and focusing on Bitcoin, has recently made headlines with its legal actions against key figures associated with LZGI International, Inc. In a significant move, Genius Group has filed an amended complaint under the Racketeer Influenced and Corrupt Organizations Act (RICO), targeting Peter Ritz and Michael Moe, who are viewed as controlling officers and directors of LZGI.

Details of the Amended Complaint

The amended complaint also adds Michael Carter and John Clayton to the list of defendants. This strategic inclusion aligns with the ongoing investigation related to the allegations by the United States and Exchange Commission (SEC) claiming a scheme of securities fraud involving small public companies, including LZGI. Genius Group asserts that these parties played a critical role in the RICO enterprise linked to their dealings with LZGI.

The Allegations Against Ritz and Moe

Central to this legal dispute are claims that Ritz and Moe attempted to deceive Genius Group by filing false statements that misled the courts. Their actions reportedly led to the issuance of a Temporary Restraining Order (TRO) and a Preliminary Injunction (PI) restricting Genius Group from raising funds and acquiring Bitcoin. This position not only obstructed the Company's operations but was perceived as an act to extort additional funds from Genius Group.

Recent Court Rulings Favoring Genius Group

In a favorable turn of events, the United States Court of Appeals for the Second Circuit issued a stay on the preliminary injunction on May 6, affirming Genius Group's potential for success in this case and highlighting the clear harm the Company faced without this stay. This court ruling allows Genius Group to resume its normal business activities immediately, including fundraising, stock sales, purchasing Bitcoin, and supporting its overall growth.

Moving Forward Post-RULING

With the legal landscape becoming more favorable, Genius Group is now focusing its efforts on restructuring its operations and addressing the damages sustained due to the TRO and PI, which have escalated to $250 million. The Company is pursuing treble damages, seeking an impressive $750 million related to the RICO allegations as it embarks on the recovery phase.

Legal Representation and Cooperation with Shareholders

The Company’s legal strategy is spearheaded by experienced attorneys Mark R. Basile and Alyssa Feldman from the Basile Law Firm P.C., a firm recognized for its expertise in RICO litigation. Additionally, Genius Group has shown solidarity with the LZGI shareholders by cooperating with their Class Action lawsuit against Ritz and Moe, which focuses on federal securities law violations.

Security and Recent Events

In the wake of recent security concerns, including a hacking incident involving CEO Roger Hamilton's social media account, Genius Group has been proactive. The Company engaged directly with the social media platform to secure and recover the account, and it continues to investigate any possible connections to its ongoing legal challenges.

Looking Ahead

As Genius Group navigates through these legal hurdles, the Company remains dedicated to delivering quality education through its innovative solutions in AI and Bitcoin. With an active user base of 5.8 million across more than 100 countries, Genius Group is poised for growth and innovation, eager to overcome these challenges for the benefit of its users and stakeholders.

Frequently Asked Questions

What is the current lawsuit filed by Genius Group about?

The lawsuit involves allegations of fraud against Peter Ritz and Michael Moe related to their roles at LZGI, seeking damages of $750 million under RICO.

Who are the additional defendants in the amended complaint?

The amended complaint includes Michael Carter and John Clayton, who are also involved in a related SEC investigation.

What has the court decided regarding Genius Group's operations?

The U.S. Court of Appeals granted a stay on the injunction, allowing Genius Group to resume its operations and fundraising efforts.

How much in damages is Genius Group pursuing?

Genius Group is seeking treble damages amounting to $750 million due to the actions of the defendants impacting their operations.

What actions is Genius Group taking in response to the legal situation?

The Company is restructuring its operations, cooperating with affected shareholders, and actively pursuing legal avenues to recover losses.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 120

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 106

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 138

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 244

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 95

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading

Top 5 Most Recently Viewed Articles

Under Armour and UNLESS: A New Era in Sustainable Sportswear

Updated Category News Views 185

Under Armour and UNLESS Unveil Groundbreaking Sportswear Innovative Launch at Milan Design Week Under Armour, Inc. and UNLESS, Inc. are set to revolutionize the sportswear industry by introducing a remarkable regenerative sportswear collection during Milan Design Week. This innovative project is a significant milestone representing their first collaboration, focusing on...

Continue Reading
Primech Holdings Expands Reach in North America, Targets Growth

Updated Category News Views 111

Primech Holdings Expands Presence in North America Primech Holdings Limited (NASDAQ: PMEC) has marked a significant milestone by opening its United States office in Edwardsville, Illinois. This expansion into North America is driven by the increasing demand for advanced, AI-driven cleaning solutions among institutional clients. Strategic Location for Growth Illinois was...

Continue Reading
Quantum Computing Inc. Secures $500 Million Through Private Placement

Updated Category News Views 296

Quantum Computing Inc. Strengthens Financial Backbone Quantum Computing Inc. (NASDAQ: QUBT), a pioneering company in the realm of integrated photonics and quantum optics technologies, has made headlines with its significant financing move. Recently, QCi announced that it has successfully arranged a private placement of common stock, amassing $500 million. This capital...

Continue Reading
Glaukos Takes Major Step with Epioxa™ FDA Application

Updated Category News Views 80

Glaukos Takes Major Step with Epioxa™ FDA Application Glaukos Corporation (NYSE: GKOS), a distinguished ophthalmic pharmaceutical and medical technology enterprise, has made significant strides by filing a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Epioxa™, its state-of-the-art keratoconus therapy. This innovative treatment...

Continue Reading
Freshpet's Upcoming Q1 2025 Results and Company Growth Insights

Updated Category News Views 222

Freshpet to Share First Quarter Results for 2025 Freshpet, Inc. is set to disclose its financial results for the first quarter concluding on March 31, 2025. The announcement is scheduled for the morning of May 5, 2025, just before the market opens. As a public company operating under Nasdaq: FRPT, Freshpet has garnered significant attention in the pet food industry....

Continue Reading